Marcus Wiedmann

2.5k total citations
59 papers, 1.9k citations indexed

About

Marcus Wiedmann is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marcus Wiedmann has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 22 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Marcus Wiedmann's work include Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Gallbladder and Bile Duct Disorders (12 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Marcus Wiedmann is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Gallbladder and Bile Duct Disorders (12 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Marcus Wiedmann collaborates with scholars based in Germany, Austria and United States. Marcus Wiedmann's co-authors include Joachim Mössner, Karel Caca, Frieder Berr, Zixu Mao, Andrea Tannapfel, Helmut Witzigmann, Johann Hauss, Christian Wittekind, Ulrich Halm and Konrad Schoppmeyer and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Clinical Oncology.

In The Last Decade

Marcus Wiedmann

55 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Wiedmann Germany 22 858 738 532 520 273 59 1.9k
Valerie Gouon–Evans United States 22 911 1.1× 297 0.4× 1.4k 2.7× 720 1.4× 368 1.3× 32 3.0k
Ivett Jelinek Hungary 8 723 0.8× 549 0.7× 703 1.3× 240 0.5× 34 0.1× 13 2.6k
Laura Porretti Italy 27 347 0.4× 216 0.3× 840 1.6× 219 0.4× 156 0.6× 72 2.1k
Lora W. Barsky United States 27 332 0.4× 341 0.5× 780 1.5× 352 0.7× 112 0.4× 39 2.1k
Gary Wildey United States 22 281 0.3× 233 0.3× 932 1.8× 621 1.2× 73 0.3× 53 1.8k
Kantima Leelahavanichkul United States 9 630 0.7× 506 0.7× 822 1.5× 337 0.6× 28 0.1× 12 2.5k
Zeyang Ding China 28 248 0.3× 279 0.4× 853 1.6× 429 0.8× 192 0.7× 92 1.8k
Stefano Buttiglieri Italy 20 447 0.5× 158 0.2× 793 1.5× 359 0.7× 189 0.7× 29 1.6k
Ewa Iżycka‐Świeszewska Poland 20 196 0.2× 359 0.5× 412 0.8× 367 0.7× 38 0.1× 136 1.5k
Sean Preston United Kingdom 15 596 0.7× 253 0.3× 575 1.1× 496 1.0× 55 0.2× 25 1.6k

Countries citing papers authored by Marcus Wiedmann

Since Specialization
Citations

This map shows the geographic impact of Marcus Wiedmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Wiedmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Wiedmann more than expected).

Fields of papers citing papers by Marcus Wiedmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Wiedmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Wiedmann. The network helps show where Marcus Wiedmann may publish in the future.

Co-authorship network of co-authors of Marcus Wiedmann

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Wiedmann. A scholar is included among the top collaborators of Marcus Wiedmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Wiedmann. Marcus Wiedmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiedmann, Marcus, et al.. (2013). New and emerging combination therapies for esophageal cancer. Cancer Management and Research. 5. 133–133. 23 indexed citations
2.
Wiedmann, Marcus & Joachim Mössner. (2011). Molecular Targeted Therapy of Hepatocellular Carcinoma – Results of the First Clinical Studies. Current Cancer Drug Targets. 11(6). 714–733. 11 indexed citations
3.
Wiedmann, Marcus & Joachim Mössner. (2010). Molecular Targeted Therapy of Biliary Tract Cancer – Results of the First Clinical Studies. Current Drug Targets. 11(7). 834–850. 31 indexed citations
4.
Wiedmann, Marcus, et al.. (2009). Fracture of a covered self-expanding antireflux stent in two patients with distal esophageal carcinoma. Endoscopy. 41(S 02). E129–E130. 15 indexed citations
5.
Wiedmann, Marcus, Joachim Mössner, C. Baerwald, & Matthias Pierer. (2009). TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases. Endocrine Metabolic & Immune Disorders - Drug Targets. 9(3). 295–314. 28 indexed citations
6.
Witzigmann, Helmut, Marcus Wiedmann, Christian Wittekind, Joachim Mössner, & Johann Hauss. (2008). Therapeutical Concepts and Results for Klatskin Tumors. Deutsches Ärzteblatt international. 105(9). 156–61. 7 indexed citations
7.
Niederhagen, Manuel, et al.. (2008). Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors. World Journal of Gastroenterology. 14(23). 3681–3681. 25 indexed citations
8.
Herman, Steven A., et al.. (2007). Performance characteristics of a new multiplex NAT screening test for HBV, HCV and HIV. the COBAS TAQSCREEN MPX Test on the COBAS S 201 system. Vox Sanguinis. 91. 1 indexed citations
9.
Feisthammel, Jürgen, et al.. (2007). Irinotecan With 5-FU/FA in Advanced Biliary Tract Adenocarcinomas. American Journal of Clinical Oncology. 30(3). 319–324. 35 indexed citations
10.
Neumann, Susanne, Konrad Schoppmeyer, Thoralf Lange, et al.. (2007). Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease. Gastrointestinal Endoscopy. 65(3). 403–409. 47 indexed citations
11.
12.
Schoppmeyer, Konrad, Marcus Wiedmann, André Liebmann, et al.. (2006). Radiochemotherapy Followed by Gemcitabine and Capecitabine in Extrahepatic Bile Duct Cancer. American Journal of Clinical Oncology. 29(6). 576–582. 9 indexed citations
13.
Wiedmann, Marcus & Karel Caca. (2005). Molecularly Targeted Therapy for Gastrointestinal Cancer. Current Cancer Drug Targets. 5(3). 171–193. 69 indexed citations
14.
Wiedmann, Marcus, et al.. (2005). Transdermales Buprenorphin in der Schwangerschaft. Der Schmerz. 20(4). 334–337. 5 indexed citations
15.
Wiedmann, Marcus & Karel Caca. (2004). General Principles of Photodynamic Therapy (PDT) and Gastrointestinal Applications. Current Pharmaceutical Biotechnology. 5(4). 397–408. 31 indexed citations
16.
Wiedmann, Marcus, et al.. (2003). Evaluation of Three Commercial Assays for the Detection of Hepatitis A Virus. European Journal of Clinical Microbiology & Infectious Diseases. 22(2). 129–130. 12 indexed citations
17.
Wiedmann, Marcus, Karel Caca, Frieder Berr, et al.. (2003). Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma. Cancer. 97(11). 2783–2790. 131 indexed citations
18.
Wiedmann, Marcus, et al.. (2002). Rezidivierende untere gastrointestinale Blutung bei einem 38-jährigen Patienten. DMW - Deutsche Medizinische Wochenschrift. 127(21). 1130–1133.
19.
Wiedmann, Marcus, Uwe G. Liebert, U. Oesen, et al.. (2000). Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology. 31(1). 230–234. 131 indexed citations
20.
Bielecki, Krzysztof, et al.. (1994). Effect of 5-Fluorouracil on Secretion and Synthesis of Pancreatic Digestive Enzymes. Pancreas. 9(4). 518–525. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie Gouon–Evans Breakdown of academic impact, for papers by Ivett Jelinek Breakdown of academic impact, for papers by Laura Porretti Breakdown of academic impact, for papers by Lora W. Barsky Breakdown of academic impact, for papers by Gary Wildey Breakdown of academic impact, for papers by Kantima Leelahavanichkul Breakdown of academic impact, for papers by Zeyang Ding Breakdown of academic impact, for papers by Stefano Buttiglieri Breakdown of academic impact, for papers by Ewa Iżycka‐Świeszewska Breakdown of academic impact, for papers by Sean Preston
Rankless by CCL
2026